ВЛИЯНИЕ ЦИТОКИНОВ НА КОМОРБИДНОСТЬ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА И АФФЕКТИВНЫХ РАССТРОЙСТВ ТРЕВОЖНО-ДЕПРЕССИВНОГО СПЕКТРА
https://doi.org/10.15789/1563-0625-2010-3-235-240
Аннотация
Об авторах
С. Н. КозловаРоссия
А. В. Голубев
Россия
Ю. C. Крылова
Россия
К. А. Сысоев
Россия
Е. В. Шляхто
Россия
Н. Г. Незнанов
Россия
Арег А. Тотолян
Россия
Список литературы
1. Андросова Л.В., Кушнер С.Г., Абрамова Л.И., Олейчик И.В., Егорова М.Ю. Уровень интерлейкинов при эндогенных депрессиях//Журнал неврологии и психиатрии им. С.С. Корсакова. -2001. -Т. 101. -С. 45-48
2. Anisman H., Ravindran A.V., Griffiths J., Merali Z. Interleukin-1 beta production in dysthymia before and after pharmacoterapy//Biol. Psychiatr. -1999. -Vol. 46. -P. 1649-1655.
3. Barefoot J.C., Helms M.J., Mark D.V. Depression and long-term mortality risk in patients with coronary artery diseas//Am. J. Cardiol. -1996. -Vol. 78. -P.613-617.
4. Besedovsky H.O., delRay A., Sorkin A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones//Science. -1986. -Vol. 233. -P. 652-654.
5. Connor T.J., Leonard B.E.//Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sciences. -1998. -Vol. 62. -P. 583-606.
6. Coppen A., Wood K. Triptophan and depressive illness//Psychol. Med.. -1978. -Vol. 8. -P. 49-57.
7. Coryell W., Noyes R., House J.D. Mortality among outpatients with anxiety disorders//Am. J. Psychiatr. -1986. -Vol. 14, N 3. -P. 508-510.
8. Dicknes C., McGowan L., Clark-Carter D. Depression in rheumatoid arthritis, a systematic review of the literature with meta-analysis//Psychosom. Med. -2002. -Vol. 64. -P. 52-60.
9. Felger J.C., Alagbe O., Hu F., Mook D., Freeman A.A., Sanchez M.M., Kalin N.H., Ratti E., Nemeroff C.B., Miller A.H. Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression//Biol. Psychiatr. -2007. -Vol. 62. -P. 1324-1333.
10. Hamilton M. Hamilton anxiety scale//In: Gue W. ed. ECDEU Assessment manual for psycholopharmacology: Rev. Ed. Washington DC: US Department of Health, Education and Welfare. -1976. -P. 193-198.
11. Hamilton M. A rating for depression//J. Neurol. Neurosurg. Psychiatr. -1960. -Vol. 23. -P. 56-61.
12. Hardardottir I., Grunfeld C., Feingold K.R. Effects of endotoxin and cytokines on lipid metabolism//Curr. Opin. Lipidol. -1994. -Vol. 5 -P. 207-215.
13. Kim J.J., Diamond D.M. The stressed hippocampus, synaptic plasticity and lost memories//Nature Reviews Neurocs. -2002. -Vol. 3. -P. 453-462.
14. Konsman J.P., Parnet P., Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications//Trends. Neurosci. -2002. -Vol. 25. -P. 154-159.
15. Kronfol Z. Immune dysregulation in major depression: a critical review of exesting evidence//Int. J. Neuropsychopharmacol. -2002. -Vol. 5. -P. 333-343.
16. Lacroix S., Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain//J. Neurochem. -1998. -Vol. 70. -P. 452-466.
17. Licinio J. Central nervous system cytokines and their relevance for neurotoxicity and apoptosis//J. Neural. Transmission (Suppl.). -1997. -Vol. 49. -P. 169-175.
18. Licinio J., Wong M.-L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems and contribute to neurotoxicity and neuroprotection//Mol. Psychiatr. -1999. -Vol. 4. -P. 317-327.
19. Marshall P.S. Allergy and depression, a neurochemical threshold model of the relation between the illnesses//Psychol. Bull. -1993. -Vol. 113. -P. 23-24.
20. McAdam W. Aspirin.//In: Cohen M. ed. Handbook of Antiplatelet Therapy. London: Martin Dunitz. -2003. -P. 71-95.
21. Minden S.L., Schiffer R.B. Affective disorders in multiple sclerosis // Review and recommendations for clinical research // Acch. Neurol. - 1990. - Vol. 47. - P. 98-104.
22. Mosovich S.A., Boone R.T., Reichenberg A. New insights into the link between cardiovascular disease and depression//Int. J. Clin. Pract. -2008. -Vol. 62. -P. 423-432.
23. Myint A.M., Mahony S., Kubera M., Kim Y.K., Kenny C., Kaim-Basta A., Steinbush H.W., Leonard B.E. Role of paroxetine in interferon-alpha-induced immune and behavioural changes in male Wistar rats.//J. Psychopharmacol. -2007. -Vol. 21. -P. 843-850.
24. Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter//Clin. Chem. -1994. -Vol. 40. -P. 288-295.
25. Pitossi F., del Rey A., Kabiersch A., Besedovsky H. Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice//J. Neurosci. Research. -1997. -Vol. 48. -P. 287 -298.
26. Quarantini L.C., Bressan R.A., Galvao A., Batista-Neves S., Parana R., Miranda-Scippa A. Incidence of psychiatric side effects during regulated interferon-alpha retreatment in nonresponder hepatitis C virus-infected patients//Liver Int. -2007. -Vol. 27. -P. 1098-1102.
27. Rivest S., Lacroix S., Vallieres L., Nadeau S., Zhang J., Laflamme L. How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli//Proceedings of the Society for Experimental Biology and Medicine. -2000. -Vol. 223. -P. 22-38.
28. Schloesser R.J., Huang J., Klein P.S., Manji H.K. Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder//Neuropsychopharmacol. -2008. -Vol. 33. -P. 110 -133.
29. Sheline Y.I., Bardgett M.E., Jackson J.L. Platelet serotonin markers and depressive symptomatology//Biol. Psychiatr. -1995. -Vol. 37. -P. 442-447.
30. Silvermann M.N., Pearse B.D., Miller A.H. Cytokines and HPA axis regulation//In: Kronfol Z. Editor. Cytokines and Mental Health, Kluwer, Norvell, Maas. -2003. -P. 85-122.
31. Smith R.S. The macrophage theory of depression//Med. Hypothesis. -1991. -Vol. 35. -P. 298-306.
32. Tsao C.W., Lin Y.S., Chen C.C., Bai C.H., Wu S.R. Cytokines and serotonin transporter in patients with major depression//Progress in Neuropsychopharmacol. and Biological Psychiatry. -2006. -Vol. 30. -P. 899-905.
33. Weisse C.S. Depression and immuno-competence, a review of the literature//Psych. Bull. -1992. -Vol. 111. -P. 475-489.
34. Whooley M.A., Caska C.M., Hendrickson B.E. et al. Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul study//Biol. Psychiatr. -2007. -Vol. 62. -P. 314-320.
35. Zigmond A.S., Snaith R.P. The Hospital Anxiety and Depression scale//Acta Psychiatr. Scand. -1983. -Vol. 67. -P. 361-370.
Рецензия
Для цитирования:
Козлова С.Н., Голубев А.В., Крылова Ю.C., Сысоев К.А., Шляхто Е.В., Незнанов Н.Г., Тотолян А.А. ВЛИЯНИЕ ЦИТОКИНОВ НА КОМОРБИДНОСТЬ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА И АФФЕКТИВНЫХ РАССТРОЙСТВ ТРЕВОЖНО-ДЕПРЕССИВНОГО СПЕКТРА. Медицинская иммунология. 2010;12(3):235-240. https://doi.org/10.15789/1563-0625-2010-3-235-240
For citation:
Kozlova S.N., Golubev A.V., Krylova U.S., Syssoev K.A., Shlyakhto E.V., Neznanov N.G., Totolian A.A. IMPACT OF CYTOKINES UPON COMORBID STATES OF CORONARY ARTERY DISEASE AND AFFECTIVE DISORDERS ASSOCIATED WITH DEPRESSION AND ANXIETY. Medical Immunology (Russia). 2010;12(3):235-240. (In Russ.) https://doi.org/10.15789/1563-0625-2010-3-235-240